Auriga - Our Business is Your Health
Capitalizing on high-revenue markets and opportunities in the pharmaceutical industry through proactive sales, integrated marketing and advanced in-house drug development capabilities
No forums with this name found
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Fast Facts

Name Symbol Exchange
Auriga Laboratories Inc. ARGA OTCBB
Shares Outstanding Financials Industry
View Filings Technology & Medical
Transfer Agent   Website
Computershare Investor Services   http://www.aurigalabs.com...

Recent Updates

Press Release - Jun 07, 07 04:34AM
NEWS - Auriga Laboratories Acquires Exclusive U.S. Rights to New Hair Loss Product
Press Release - May 24, 07 04:00AM
News - Auriga Laboratories Acquires Exclusive License to Market Unique New Intranasal Lubricant
Press Release - May 09, 07 04:50AM
NEWS - Auriga Laboratories Appoints Elliot M. Maza To Its Board of Directors
Press Release - May 02, 07 04:54AM
NEWS - Auriga Laboratories Appoints Steven D. Gallopo As Vice President of Business Development
Press Release - Apr 16, 07 04:52AM
NEWS - Auriga Laboratories Reports Record 2007 First Quarter Financial Results

Top Rated Messages

Sorry, no rated messages found

See more top rated messages

Most Recent Messages

Why such a drop
442rocks
Oct 02, 07 04:23AM
Re: what's happening??
rileymartin
Aug 14, 07 02:53PM
what's happening??
rileymartin
Jul 24, 07 02:54PM
Hair-loss drugs in combination
Freedom35
Jul 05, 07 12:12PM
Re: NEWS - Auriga Laboratories Acquires Exclusive U.S. Rights to New Hair Loss Product
Europeman
Jul 03, 07 12:07PM
Go to Full Discussion Forum

AGORACOM Quick Tips

AGORACOM 100 - The Top 100 Small Caps ... Find Your Next Investment
Click To Watch Today's Show

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote

Open ARGA Stock Quote

Investment Ideas

Like Auriga Laboratories Inc.? Then you might also be interested in AlphaRx

AlphaRx
  • Initiated Product Registration in China
  • Moving Towards Pivotal Phase III Trials
  • Multi Billion Dollar Market Opportunity